CPI STEM CELL THERAPY: A COST-BENEFIT ANALYSIS

Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive approach. Supporters often highlight the opportunity for meaningful therapeutic outcomes, especially in diseases where conventional medications have proven inadequate. However, crucially important to assess the significant financial burden associated with CPI